Population
Patients with essential hypertension (general discussion)
Design
Review
Authors
Loading...
Clinicians should view uncontrolled hypertension reports skeptically; leaves open true efficacy of many therapies pending rigorous trials.
Highlights methodological flaws, such as inadequate control periods, that lead to erroneous conclusions about blood pressure reduction therapies in essential hypertension.
David Ayman (1931) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: